Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 27, 2014	4	Statement of changes in beneficial ownership of securities	0001209191-14-023435.pdf 0001209191-14-023435.rtf 0001209191-14-023435.xls View HTML
March 27, 2014	4	Statement of changes in beneficial ownership of securities	0001209191-14-023440.pdf 0001209191-14-023440.rtf 0001209191-14-023440.xls View HTML
March 27, 2014	4	Statement of changes in beneficial ownership of securities	0001209191-14-023439.pdf 0001209191-14-023439.rtf 0001209191-14-023439.xls View HTML
March 27, 2014	4	Statement of changes in beneficial ownership of securities	0001209191-14-023441.pdf 0001209191-14-023441.rtf 0001209191-14-023441.xls View HTML
March 28, 2014	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001144204-14-018572.pdf 0001144204-14-018572.rtf 0001144204-14-018572.xls View HTML
March 28, 2014	8-K	Report of unscheduled material events or corporate event	0001193125-14-121774.pdf 0001193125-14-121774.rtf 0001193125-14-121774.xls View HTML
March 31, 2014	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-14-024204.pdf 0001104659-14-024204.rtf 0001104659-14-024204.xls View HTML
April 3, 2014	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-14-129642.pdf 0001193125-14-129642.rtf 0001193125-14-129642.xls View HTML
April 29, 2014	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001144204-14-025779.pdf 0001144204-14-025779.rtf 0001144204-14-025779.xls View HTML
May 12, 2014	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001193125-14-193535.pdf 0001193125-14-193535.rtf 0001193125-14-193535.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax